切换至 "中华医学电子期刊资源库"

中华介入放射学电子杂志 ›› 2016, Vol. 04 ›› Issue (03) : 132 -135. doi: 10.3877/cma.j.issn.2095-5782.2016.03.002

所属专题: 文献

肿瘤介入

外放疗联合个体化导板辅助125I放射性粒子植入治疗晚期头颈部鳞癌
王兴1, 孟箭1,(), 李志萍1, 庄乾伟1, 葛良玉1   
  1. 1. 221009 徐州,徐州市中心医院口腔科
  • 收稿日期:2016-05-21 出版日期:2016-08-01
  • 通信作者: 孟箭
  • 基金资助:
    江苏省"六大人才高峰"D类项目(2012-WS-099); 徐州市医学创新(技术攻关)领军人才项目(XWCX201604)

External beam radiation therapy combined with individual template assisted iodine 125 radioactive seed implant for head and neck squamous cell carcinoma

Xing Wang1, Jian Meng1,(), Zhiping Li1, Qianwei Zhuang1, Liangyu Ge1   

  1. 1. Department of Stomatology, Xuzhou Central Hospital , Xuzhou 221009, China
  • Received:2016-05-21 Published:2016-08-01
  • Corresponding author: Jian Meng
  • About author:
    Corresponding author: Meng Jian, Email:
引用本文:

王兴, 孟箭, 李志萍, 庄乾伟, 葛良玉. 外放疗联合个体化导板辅助125I放射性粒子植入治疗晚期头颈部鳞癌[J]. 中华介入放射学电子杂志, 2016, 04(03): 132-135.

Xing Wang, Jian Meng, Zhiping Li, Qianwei Zhuang, Liangyu Ge. External beam radiation therapy combined with individual template assisted iodine 125 radioactive seed implant for head and neck squamous cell carcinoma[J]. Chinese Journal of Interventional Radiology(Electronic Edition), 2016, 04(03): 132-135.

目的:

探讨外放疗联合个体化导板辅助125I放射性粒子植入治疗无法手术的头颈部鳞癌的可行性及不良反应。

方法:

对17例因全身系统疾病而无法手术的头颈部鳞癌患者进行常规分割放疗联合个体化导板辅助125I放射性粒子植入增量放疗。外放疗总照射剂量为50 Gy,放射性粒子匹配周缘剂量(matched peripheral dose, MPD)为80~120 Gy。

结果:

通过肿瘤体积变化情况和临床表现评价治疗标准,17例患者治疗总有效率达到82.4%(14/17),1例死于大出血。主要的不良反应包括:软组织坏死、局部出血及放射性黏膜炎和皮炎等,治疗过程未发生急性并发症与严重的放射性损伤。

结论:

外放疗联合个体化导板辅助125I放射性粒子植入治疗晚期头颈部鳞癌,是一种微创、有效、安全性高的治疗方案。

Objective:

This study aims to investigate the feasibility and side effects of external beam radiation therapy combined with individual template assisted iodine 125 radioactive seed implant in the treatment of advanced unresectable head and neck squamous cell carcinoma (HNSCC).

Methods:

17 patients with histologically documented advanced HNSCC, who were unable to receive surgical treatment due to their physical condition, underwent external beam radiation therapy combined with individual template assisted iodine 125 radioactive seed implant.. All patients had conventional fractionated external radiotherapy with a total dose of 50 Gy, and the matched peripheral dose of iodine 125 seed was 80~120 Gy.

Results:

The outcome of the treatment was evaluated based on changes of tumor size and patients’ clinical symptoms. The overall responding rate among these patients was 82.4% (14/17) . One patient died of hemorrhage. Major side effects included soft tissue necrosis, local hemorrhage, radiation mucositis and dermatitis. No other acute complications or treatment related radiation damages were observed in the study.

Conclusions:

The scheme of external beam radiation therapy combined with individual template assisted iodine 125 radioactive seed implant is a relatively invasive, effective and safe regimen for advanced head and neck squamous cell carcinoma.

图1 个体化引导模板
图2 粒子术中导板引导下插植
图3 左侧腮腺鳞癌治疗前后增强CT图像
1
Agarwal JP, Nemade B, Murthy V, et al. Hypofractionated, palliative radiotherapy for advanced head and neck cancer[J]. Radiother Oncol, 2008,89(1):51-56.
2
Das S, Thomas S, Pal SK, et al. Hypofractionated palliative radiotherapy in locally advanced inoperable head and neck cancer: CMC vellore experience[J]. Indian J Palliat Care, 2013,19(2):93-98. doi: 10.4103/0973-1075.116709.
3
Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma[J]. J Natl Cancer Inst, 1999,91(24):2081-2086.
4
王俊杰, 修典荣, 冉维强. 放射性粒子组织间近距离治疗肿瘤[M]. 2版. 北京大学医学出版社, 2004: 26-61.
5
Gregoire V, Levendag P, Ang KK, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines[J]. Radiother Oncol, 2003, 69: 227-236.
6
Gomez-Roca C, Koscielny S, Ribrag V, et al. Tumour growth rates and RECIST criteria in early drug development[J]. Eur J Cancer, 2011,47(17):2512-2516.
7
Denis F, Garaud P, Bardet E, et al. Late toxicity results of the GORTEC 94-01 randomized trial comparing radiotherapy with concomitant radiochemotherapy for advanced-stage oropharynx carcinoma: comparison of LENT/SOMA, RTOG/EORTC, and NCI-CTC scoring systems[J]. Int J Radiat Oncol Biol Phys, 2003,55(1):93-98.
8
Meng J, Meng QF, Gu QP, et al. Radioactive seed implantation combined with prosthesis denture in treatment of oral and maxillofacial malignancy[J]. Cell Biochem Biophys, 2013,67(3):1529-1532. doi: 10.1007/s12013-013-9656-y.
9
Meng J, Zhang J, Zhuang Q, et al. TPS- guided I-125 implantation in patients with oral carcinoma[J]. Eur Rev Med Pharmacol Sci,2014, 14(2): 2803-2807.
10
张杰,郑磊,黄明伟,等.放射性粒子组织间植入治疗口腔颌面-头颈部腺源性恶性肿瘤近期临床疗效分析[J].北京大学学报医学版,2011,43(2):272-275.
11
黄鹂, 王俊杰, 刘敬佳, 等. 125I粒子持续低剂量率照射对人舌鳞癌细胞的抑制作用[J]. 中华放射医学与防护杂志, 2015, 35(3): 195-197. doi:10.3760/cma.j.issn.0254-5098.2015.03.008.
12
李志, 姜彬, 杨志永, 等. 基于实验与蒙特卡罗模拟法探究125I粒子间剂量衰减[J]. 中华放射医学与防护杂志, 2015, 35(5):389-392. doi:10.3760/cma.j.issn.0254-5098.2015.05.019.
13
王兴, 孟箭. 125I粒子植入治疗高龄非霍奇金淋巴瘤并吞咽困难一例[J]. 中华全科医师杂志, 2015,14(5):388-389. doi:10.3760/cma.j.issn.1671-7368.2015.05.021.
14
李锐, 付坤, 高宁, 等. MRI导航下125I治疗颌面部腺源性恶性肿瘤效果初探[J]. 中华口腔医学杂志, 2016,51(6): 346-349. doi:10.3760/cma.j.issn.1002-0098.2016.06.006.
[1] 陈育贞, 马育璇, 王东方, 黄代营. 舌癌放射性125I粒子组织间植入的护理体会[J]. 中华口腔医学研究杂志(电子版), 2017, 11(03): 189-191.
[2] 王兴, 孟箭, 顾倩平, 张杰, 辜建敏, 韩琨. 125I放射性粒子植入联合TPF方案治疗无法手术的头颈部鳞癌[J]. 中华口腔医学研究杂志(电子版), 2015, 09(05): 395-399.
[3] 南方护骨联盟前列腺癌骨转移专家组. 前列腺癌骨转移诊疗专家共识(2023版)[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 201-208.
[4] 丁向前, 杨璐瑶, 李珍珠, 王清波, 陈正, 孙其凯, 耿鑫, 李泽福. 三维打印个体化导板定位下微创穿刺HCH的疗效探讨[J]. 中华神经创伤外科电子杂志, 2017, 03(05): 260-263.
[5] 李刚, 王全义, 苏金旺, 丁洁, 高鹏, 陈学波. 新型125I双链胆道引流管治疗胆管癌合并黄疸的近期疗效(附9例报告)[J]. 中华介入放射学电子杂志, 2021, 09(04): 403-406.
[6] 陈建建, 姚远, 周学良, 焦德超, 韩新巍. 金属支架联合腔道内抗肿瘤技术治疗恶性胆道梗阻的研究现状及进展[J]. 中华介入放射学电子杂志, 2019, 07(02): 163-167.
[7] 齐莉恩, 王红, 孟箭, 王兴. 个体化导板辅助125I放射性粒子植入治疗头颈部恶性肿瘤的手术护理[J]. 中华介入放射学电子杂志, 2017, 05(02): 102-105.
[8] 王兴, 孟箭, 顾倩平, 张杰. PET-CT在晚期上颌骨恶性肿瘤放射性粒子植入治疗中的应用价值研究[J]. 中华介入放射学电子杂志, 2016, 04(03): 142-145.
阅读次数
全文


摘要